Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

NCT03671265 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: SHR-1210
RADIATION: IMRT or VMAT
DRUG: Apatinib

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]